Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project
Year: 2018
Type: review
Abstract: In the last 10 years tremendous progress has been made in the development of artificial pancreas (AP) systems for people with type 1 diabetes (T1D). The pan-European consortium CLOSE (Automated Glu cose Contro l at H ome for People with Chronic Disea se) is aiming to develop integrated AP solutions (APplus) tailored to the needs of people with type 2 diabetes (T2D). APplus comprises a product and service package complementing the AP system by obligatory training as well as home visits and telemedical consultations on demand. Outcome predictors and performance indicators shall help to identify people who could benefit most from AP usage and facilitate the measurement of AP impact in diabetes care. In a first step CLOSE will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences, and enhancing AP functionalities and interconnectedness. By being part of the European Institute of Innovation and Technology (EIT) Health public-private partnership, CLOSE is committed to the EIT "knowledge triangle" pursuing the integrated advancement of technology, education, and business creation. Putting stakeholders, education, and impact into the center of APplus advancement is considered key for achieving wide AP use in T2D care.
Authors: Freimut Schliess, Tim Heise, Carsten Benesch, Beata Mianowska, Constance Stegbauer, Björn Broge, Pieter Gillard, George Binkley, Véronique Crône, Sébastien Carlier, Cécile Delval, Anton Petkov, Jan-Philipp Beck, Volker Lodwig, Mikolaj Gurdala, Joachim Szecsenyi, Magda Rosenmöller, Katarzyna Cypryk, Chantal Mathieu, Eric Renard, Lutz Heinemann
Institutions: Profil Institute for Metabolic Research, Medical University of Lodz, KU Leuven, IESE Business School, Air Liquide (France), Sanofi (Germany), EIT Health, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institut de Génomique Fonctionnelle
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,900
Funders: Sanofi, European Commission, EIT Health
Award: G574534043
OpenAlex ID: W2893949245
